Clinical Trial Detail

NCT ID NCT04082572
Title Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Pembrolizumab

Age Groups: adult senior

Additional content available in CKB BOOST